Synova backs Kinapse

The capital will go towards funding the company' organic growth and possible strategic acquisitions.

The GP said in a statement it hopes the company will benefit from increasing regulation in the life sciences sector and pharma's drive to reduce cost.

Synova typically invests in UK-based companies valued at £5-30m.

Company
Kinapse provides outsourced and consultancy services to the global life sciences industry, particularly in the areas of regulation and compliance.

The company is based in London and has further offices in the UK, India and the US. It was founded by two former Accenture partners in 2005.

People
Philip Shapiro is managing partner at Synova and director of Kinapse.

Advisers
Equity – CIL, Alex Marshall (Commercial due diligence); BDO, Matt Copley (Financial due diligence); Travers Smith, Edmund Reed (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Industrials
• UK / Ireland
• Synova Capital
• United Kingdom